340B Rule Clarifying Parameters For Discount Drug Program Is Planned By Year-End, HRSA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Both pharmaceutical manufacturers and 340B hospitals seek more specifics on issues such as which patients are eligible to receive deeply discounted drugs through the program, how to contract with outside pharmacies and obligations of manufacturers and eligible hospitals.